Loading, please wait ...


News Analytics

yahoo default logo 1200x1200.
FibroGen disclosed "that the Cardiovascular and Renal Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) will hold an advisory committee (AdCom) meeting to review the new drug application for roxadustat in the U.S." and that FibroGen has "not received a confirmed AdCom meeting date from the FDA."

Subject Matter

  • Business, economics, society 100.00%
    • Companies, industries, organizations 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions